Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001493152-22-003365

Options or other derivatives

  • Chief Executive Officer acquired 625,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ALLEN SIMON Chief Executive Officer 2022-02-07 Grant or award · Option to purchase Common Stock +625,000 625,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…